0 Kommentare
0 Geteilt
63 Ansichten
0 Bewertungen
Suche
Entdecken Sie neue Leute, knüpfen Sie neue Kontakte und schließen Sie neue Freundschaften
-
Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
-
Clinical Oncology NGS Market: North America Emerging as a Hub for Genomic InnovationThe North America Clinical Oncology Next Generation Sequencing (NGS) market is playing a pivotal role in advancing precision oncology by enabling faster, more accurate, and comprehensive genomic profiling for cancer diagnosis and treatment selection. The United States remains at the forefront of regional growth, supported by a well-established healthcare infrastructure, increasing adoption of...0 Kommentare 0 Geteilt 615 Ansichten 0 Bewertungen
-
How Oncology Innovation Is Creating New Opportunities in the Platinum-Based Cancer Drugs MarketPolaris Market Research presents its latest market research report, titled Platinum-Based Cancer Drugs Market Size, Share, Trends, Industry Analysis Report: By Type (Cisplatin, Oxaliplatin, Carboplatin, and Others), Application, Distribution Channel, and Region – Market Forecast, 2026–2034. It is a comprehensive market research report analyzing the fast-evolving...0 Kommentare 0 Geteilt 107 Ansichten 0 Bewertungen
-
Lurbinectedin Market Size, Share, Cancer Therapeutics Innovation & Oncology Drug Development Trends | Industry Forecast to 2029The Lurbinectedin Market has emerged as a notable niche within the oncology therapeutics landscape, driven by advancements in targeted cancer treatments and rising incidence of small cell lung cancer (SCLC) and select solid tumors. The lurbinectedin market is expected to witness market growth at a rate of 45.30% in the forecast period of 2022 to...0 Kommentare 0 Geteilt 830 Ansichten 0 Bewertungen
-
Next-Generation Oncology Research Drives Innovation in the NAMPT Inhibitor MarketPolaris Market Research has published insightful research on NAMPT Inhibitor Market. The research report offers an in-depth analysis of the market, covering all the major aspects, including market size, market share, growth drivers, and key trends. Besides, a thorough assessment of the annual forecast, strategies, and potential roadmaps has been provided in the study. The data in the...0 Kommentare 0 Geteilt 192 Ansichten 0 Bewertungen
-
Oncology Nutrition Market Analysis: Investment, Innovation, and Growth Opportunities Through 2034The global Oncology Nutrition Market is expected to witness robust growth from 2025 to 2033, driven by the rising global cancer burden, increasing prevalence of cancer-related malnutrition, growing awareness of the importance of nutritional support during cancer treatment, and expanding adoption of personalized nutrition strategies. The market was valued at USD 2.8 billion in...0 Kommentare 0 Geteilt 139 Ansichten 0 Bewertungen
-
Technological Innovation and Digital Transformation in the Clinical Oncology Next Generation Sequencing MarketThe genomic oncology industry is experiencing a technological renaissance, driven by advances in sequencing technology, artificial intelligence, and digital health. The Clinical Oncology Next Generation Sequencing NGS Market is at the forefront of these innovations, valued at USD 7.32 billion in 2025 and projected to reach USD 20 billion by 2035 at a CAGR of 10.6%. This article...0 Kommentare 0 Geteilt 183 Ansichten 0 Bewertungen
-
Circular RNA Therapeutics Market Size, Industry Trends, and Growth Forecast to 2033According to the latest report published by Data Bridge Market Research, the Circular RNA Therapeutics Market The global Circular RNA Therapeutics market size was valued at USD 784 Million in 2025 and is expected to reach USD 4188.13 Million by 2033, at a CAGR of 23.30% during the forecast period To impart a supreme quality to this persuasive Circular RNA...0 Kommentare 0 Geteilt 11KB Ansichten 0 Bewertungen
-
Global Oncology Biosimilars Market Forecast to 2031: Growth Opportunities, and Future OutlookThe global Oncology Biosimilars Market is witnessing significant expansion, driven by the increasing burden of cancer and the need for cost-effective biologic therapies. The market is expected to reach US$ 26,618 million by 2031, registering a robust CAGR of 16.3% during 2025–2031. This strong growth reflects the rising adoption of biosimilars as viable alternatives to expensive biologic...0 Kommentare 0 Geteilt 1KB Ansichten 0 Bewertungen
-
Interventional Radiology Products Market Dynamics: Impact of Hybrid ORsThe healthcare industry is currently undergoing a profound shift toward minimally invasive interventions, with interventional radiology (IR) at the very center of this evolution. Interventional radiology products comprise a sophisticated suite of medical devices including catheters, stents, guidewires, and advanced imaging systems that allow physicians to diagnose and treat complex diseases...0 Kommentare 0 Geteilt 901 Ansichten 0 Bewertungen
-
Navigating International Gatekeepers: Accelerating Global Regulatory Submission WorkflowsLaunching a breakthrough therapeutic compound or advanced medical instrument into international markets requires clearing a complex web of regional regulatory bodies. From the Food and Drug Administration (FDA) in the United States to the European Medicines Agency (EMA) in Europe, each regulatory authority enforces uncompromising documentation standards. Submitting technical dossiers, chemistry...0 Kommentare 0 Geteilt 399 Ansichten 0 Bewertungen